DK0666755T3 - Inhibering af HIV-infektion - Google Patents

Inhibering af HIV-infektion

Info

Publication number: DK0666755T3
Authority: DK; Denmark
Prior art keywords: hiv infection; inhibition; slpi; prevention; methods
Prior art date: 1992-09-09

Application number

DK93921439T

Other languages

English (en)

Inventor

Stephen Eisenberg

Sharon M Wahl

Robert C Thompson

Original Assignee

Amgen Inc

Us Gov Health & Human Serv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-09

Filing date

1993-09-09

Publication date

2003-08-04

1993-09-09 Application filed by Amgen Inc, Us Gov Health & Human Serv filed Critical Amgen Inc

2003-08-04 Application granted granted Critical

2003-08-04 Publication of DK0666755T3 publication Critical patent/DK0666755T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK93921439T 1992-09-09 1993-09-09 Inhibering af HIV-infektion DK0666755T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US94336992A	1992-09-09	1992-09-09
PCT/US1993/008486 WO1994006454A2 (en)	1992-09-09	1993-09-09	Inhibitiion of retrovirus infection

Publications (1)

Publication Number	Publication Date
DK0666755T3 true DK0666755T3 (da)	2003-08-04

Family

ID=25479533

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK93921439T DK0666755T3 (da)	1992-09-09	1993-09-09	Inhibering af HIV-infektion

Country Status (23)

Country	Link
EP (1)	EP0666755B1 (da)
JP (2)	JP3517238B2 (da)
KR (1)	KR100273620B1 (da)
AT (1)	ATE238062T1 (da)
AU (1)	AU681350B2 (da)
CA (1)	CA2141951C (da)
CZ (1)	CZ286953B6 (da)
DE (1)	DE69332904T2 (da)
DK (1)	DK0666755T3 (da)
ES (1)	ES2197153T3 (da)
FI (1)	FI951078A0 (da)
HU (1)	HU218892B (da)
NO (1)	NO315546B1 (da)
NZ (1)	NZ256246A (da)
OA (1)	OA10133A (da)
PL (1)	PL307864A1 (da)
PT (1)	PT666755E (da)
RO (1)	RO116164B1 (da)
RU (1)	RU2126266C1 (da)
SG (1)	SG48115A1 (da)
SK (1)	SK281127B6 (da)
UA (1)	UA41338C2 (da)
WO (1)	WO1994006454A2 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU689559B2 (en) *	1994-03-23	1998-04-02	Mitsubishi-Tokyo Pharmaceuticals, Inc.	Novel remedy for respiratory-tract viral disease
AU6530696A (en) *	1995-07-24	1997-02-18	Tokyo Tanabe Company Limited	Remedy for viral diseases
JP2000500156A (ja)	1995-11-13	2000-01-11	フールマン，ヘラルド	ヒルから得られる抗ウイルス性単離物
DK1176193T3 (da) *	1999-05-13	2012-09-10	Japan Science & Tech Agency	Hæmmere af virusinfektion, som angriber den n-terminale region af integrase
DE10101792B4 (de) *	2001-01-17	2004-03-18	Vivotec Biomedical Technologies Gmbh	Verfahren zum Nachweis von Pankreaskarzinom oder chronischer Pankreatitis und Verwendung von Antikörpern
US8288439B2 (en)	2003-11-04	2012-10-16	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Methods and compositions for the inhibition of HIV-1 replication

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4760130A (en) *	1984-12-06	1988-07-26	Synergen Biologicals, Inc.	Serine protease inhibitors and methods for isolation of same
CA1340877C (en) *	1987-12-28	2000-01-18	Takashi Sugiyama	Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
JP2804979B2 (ja) *	1988-11-28	1998-09-30	日本ケミカルリサーチ株式会社	エイズ治療および阻害剤
CA2007083A1 (en) *	1989-01-09	1990-07-09	Nobuhiko Katunuma	Pharmaceutical use of trypstatin
AU5940090A (en) *	1989-08-16	1991-04-03	Cetus Oncology Corporation	Compositions for the inhibition of protein hormone formation and uses thereof
EP0506769B1 (fr) *	1989-12-18	1994-07-27	Transgene S.A.	Composition pharmaceutique destinee au traitement ou a la prevention des infections retrovirales
GR1001044B (el) *	1991-06-03	1993-04-28	Logothetou Rella Eleni	Μηχανισμός διή?ησης νεοπλασματικών κυττάρων και η χρήση του αναστολέα της Ca2+ -εξαρτώμενης ουδέτερης πρωτεάσης για την παρασκευή φαρμακευτικών αντικαρκινικών συν?έσεων.

1993
- 1993-09-09 JP JP50816294A patent/JP3517238B2/ja not_active Expired - Fee Related
- 1993-09-09 SG SG1996007118A patent/SG48115A1/en unknown
- 1993-09-09 AU AU48530/93A patent/AU681350B2/en not_active Ceased
- 1993-09-09 EP EP93921439A patent/EP0666755B1/en not_active Expired - Lifetime
- 1993-09-09 PT PT93921439T patent/PT666755E/pt unknown
- 1993-09-09 RU RU95109909A patent/RU2126266C1/ru not_active IP Right Cessation
- 1993-09-09 UA UA95048317A patent/UA41338C2/uk unknown
- 1993-09-09 ES ES93921439T patent/ES2197153T3/es not_active Expired - Lifetime
- 1993-09-09 PL PL93307864A patent/PL307864A1/xx unknown
- 1993-09-09 KR KR1019950700929A patent/KR100273620B1/ko not_active Expired - Fee Related
- 1993-09-09 HU HU9500682A patent/HU218892B/hu not_active IP Right Cessation
- 1993-09-09 DE DE69332904T patent/DE69332904T2/de not_active Expired - Fee Related
- 1993-09-09 DK DK93921439T patent/DK0666755T3/da active
- 1993-09-09 WO PCT/US1993/008486 patent/WO1994006454A2/en not_active Ceased
- 1993-09-09 AT AT93921439T patent/ATE238062T1/de not_active IP Right Cessation
- 1993-09-09 FI FI951078A patent/FI951078A0/fi not_active Application Discontinuation
- 1993-09-09 CA CA002141951A patent/CA2141951C/en not_active Expired - Fee Related
- 1993-09-09 CZ CZ1995559A patent/CZ286953B6/cs not_active IP Right Cessation
- 1993-09-09 NZ NZ256246A patent/NZ256246A/xx not_active IP Right Cessation
- 1993-09-09 RO RO95-00493A patent/RO116164B1/ro unknown
- 1993-09-09 SK SK297-95A patent/SK281127B6/sk unknown
1995
- 1995-03-08 NO NO19950897A patent/NO315546B1/no unknown
- 1995-03-09 OA OA60622A patent/OA10133A/en unknown
2003
- 2003-07-07 JP JP2003271629A patent/JP2004002455A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
EP0666755B1 (en)	2003-04-23
HU9500682D0 (en)	1995-04-28
JP2004002455A (ja)	2004-01-08
DE69332904D1 (de)	2003-05-28
NO950897D0 (no)	1995-03-08
AU4853093A (en)	1994-04-12
ES2197153T3 (es)	2004-01-01
JPH08505042A (ja)	1996-06-04
NZ256246A (en)	1997-08-22
SG48115A1 (en)	1998-04-17
KR100273620B1 (ko)	2000-12-15
HUT75126A (en)	1997-04-28
HU218892B (hu)	2000-12-28
KR950703357A (ko)	1995-09-20
FI951078L (fi)	1995-03-08
FI951078A7 (fi)	1995-03-08
RU95109909A (ru)	1997-03-27
WO1994006454A2 (en)	1994-03-31
NO315546B1 (no)	2003-09-22
OA10133A (en)	1996-12-18
SK29795A3 (en)	1997-02-05
WO1994006454A3 (en)	1994-08-18
CZ286953B6 (en)	2000-08-16
UA41338C2 (uk)	2001-09-17
CZ55995A3 (en)	1996-01-17
AU681350B2 (en)	1997-08-28
JP3517238B2 (ja)	2004-04-12
NO950897L (no)	1995-03-08
FI951078A0 (fi)	1995-03-08
CA2141951C (en)	2007-04-24
EP0666755A1 (en)	1995-08-16
DE69332904T2 (de)	2003-11-06
CA2141951A1 (en)	1994-03-31
ATE238062T1 (de)	2003-05-15
RO116164B1 (ro)	2000-11-30
PT666755E (pt)	2003-09-30
SK281127B6 (sk)	2000-12-11
PL307864A1 (en)	1995-06-26
RU2126266C1 (ru)	1999-02-20

Publication	Publication Date	Title
MX9706913A (es)	1997-11-29	Compuestos de bis-aminacido-hidroxietilamina-sulfonamida inhibidoresde proteasan retroviral, composiciones que los contienen y ek uso de los mismos.
BG102048A (en)	1998-08-31	Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
GEP20012471B (en)	2001-06-25	Inhibitors of Serine Proteases, Particularly Hepatitis C Virus NS3 Protease
DK0528858T3 (da)	1997-07-28	Inhibitorer af dipeptidyl-aminopeptidase type IV
ES2173341T3 (es)	2002-10-16	Compuestos inhibidores de proteasa retroviral.
NL300283I1 (nl)	2007-09-03	Alfa- en bèta-aminozuur-hydroxyethylamino-sulfonamiden die toepasbaar zijn als retrovirale-prothease-remmers.
ES2178036T3 (es)	2002-12-16	Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen.
EA199700222A1 (ru)	1998-04-30	Сульфонилалканоиламиногидроксиэтиламиносульфонамид в качестве ингибиторов ретровирусной протеазы
BG100016A (bg)	1996-04-30	Нiv протеазни инхибитори във фармацевтични комбинации за лечение на спин
NO974148L (no)	1997-10-27	Aminosyrehydroksyetylaminosulfonamid retrovirale proteaseinhibitorer
DK0815124T3 (da)	2003-03-17	Heterocyckliske carbonylaminosyre-hydroxyethylamino-sulfonamidinhibitorer af retrovirale proteaser
NO983688L (no)	1998-10-12	Serin-protease-inhibitorer
NO962017L (no)	1996-07-08	5,6-Dihydropyron - derivater som protease-inhibitorer og antivirus-midler
NO983991L (no)	1998-10-30	Serin-protease-inhibitorer
MD960172A (en)	1999-01-31	5,6-dihydropyrone derivatives as proteaze inhibitors and antiviral agents
NO934720L (no)	1994-06-23	Nye HIV protease inhibitorer
DK0666755T3 (da)	2003-08-04	Inhibering af HIV-infektion
MX9304351A (es)	1994-02-28	Inhibidores de proteasas de aminodiol y composiciones farmaceuticas que los incluyen.
MX9706912A (es)	1998-01-31	Inhibidores de protesa retroviral de sulfonamida de hidroxietilamino de amino acido y uso de los mismos.